| Company/Division name | CPC Scientific |
| Parent company | MEMC Korea Co. |
| Type of work | Manufacturing |
| Reshoring category: | Reshoring |
| Total number of jobs (added or to be added): | 50 |
| Year reshoring announced: | 2022 |
| Year reshoring implemented or to be implemented: | 2023 |
| City reshored to: | Rocklin |
| State(s) reshored to: | CA |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | clinical and commercial grade peptide products |
| What domestic positive factors made reshoring more attractive? | Eco-system synergies, Proximity to customers/market |
